Home/Filings/4/0000950170-25-075332
4//SEC Filing

CONTE LISA A 4

Accession 0000950170-25-075332

CIK 0001585608other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:00 PM ET

Size

8.4 KB

Accession

0000950170-25-075332

Insider Transaction Report

Form 4
Period: 2025-05-17
CONTE LISA A
DirectorCEO and President
Transactions
  • Exercise/Conversion

    Common Stock

    2025-05-17+2666 total
  • Exercise/Conversion

    Restricted stock units

    2025-05-1720 total
    Common Stock (2 underlying)
Footnotes (4)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On May 23, 2024, the issuer effected a 60-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "May 2024 Reverse Stock Split). Upon effectiveness of the May 2024 Reverse Stock Split, every 60 shares of voting common stock was automatically converted into one share of voting common stock. On March 18, 2025, the issuer effected a 25-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "March 2025 Reverse Stock Split").
  • [F3](Continued from footnote 2) Upon effectiveness of the March 2025 Reverse Stock Split, every 25 shares of voting common stock was automatically converted into one share of voting common stock.
  • [F4]The restricted stock units were originally approved by the issuer's board of directors on March 28, 2022 and previously reported as covering 606,280 shares, but were adjusted to reflect the January 2023 Reverse Stock Split, May 2024 Reverse Stock Split and March 2025 Reverse Stock Split. The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.

Documents

1 file

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001008377

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:00 PM ET
Size
8.4 KB